Enhanced COPD Management in Suspected Lung Cancer Patients

Sponsor
Ditte Krag-Hansen
Study ID
NCT07543601
Status
Recruiting
Apply to this trial

Conditions

  • Airflow Obstruction, Chronic
  • COPD
  • COPD (Chronic Obstructive Pulmonary Disease)
  • COPD - Chronic Obstructive Pulmonary Disease
  • Lung Cancer (Diagnosis)
  • Lung Carcinoma
  • Lung Neoplasm Malignant
  • Pulmonary Cancer
  • Pulmonary Cancers
  • Pulmonary Carcinoma
  • Pulmonary Neoplasm
  • Pulmonary Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tailored COPD consultations — OTHER
    These consultations will include assessment and treatment according to GOLD guidelines, including: Pharmacological management Smoking cessation support Referral to pulmonary rehabilitation as appropriate Referral for nutritional assessment and optimization when appropriate Referral to cardiovascular evaluation when appropriate Referral to sleep apnea evaluation when appropriate

Study Details

Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.

Key Dates

First listed
Apr 22, 2026
Start date
Mar 6, 2026
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
280 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • No Intervention: Usual care
    Lung cancer investigation only
  • Experimental: Tailored COPD consultation
    Tailored COPD consultations will include assessment and treatment according to GOLD guidelines, including: Pharmacological management Smoking cessation support Referral to pulmonary rehabilitation as appropriate Referral for nutritional assessment and optimization when appropriate Referral to cardiovascular evaluation when appropriate Referral to sleep apnea evaluation when appropriate

Primary Outcome Measure

CAT score [ Time Frame: Baseline, after 3 months and after 6 months ]

Central Contacts

Find similar trials

Nationwide
COPD trialsLung cancer trialsPulmonology trialsLung disease trialsOncology trialsLung oncology trials

Related Studies